Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 6Phase 1/2 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 44Unknown 13Active not recruiting 8Terminated 6Recruiting 6Withdrawn 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Sarcoma 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Sarcoma 1Pleuropulmonary blastoma 1Penile Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Ifosfamide × Clear all
NCT04043494 2026-05-06

LBL 2018

University Hospital Muenster

Phase 3 Recruiting
683 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

NCT03805022 2025-10-02

CIRSARC

Institut Bergonié

Phase 3 Recruiting
351 enrolled
Sarcoma

Sarcoma

NCT03643276 2025-04-06

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

University Hospital Schleswig-Holstein

Phase 3 Recruiting
5,000 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02305654 2025-04-02

InPACT

Institute of Cancer Research, United Kingdom

Phase 3 Recruiting
200 enrolled
Genitourinary

Penile Neoplasms

NCT06792253 2025-01-24

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

BeBetter Med Inc

Phase 3 Recruiting
416 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡